Cited by 53

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

Huang, Yuzhao, He, Yuchen, Makarcyzk, Meagan J., Lin, Hang·2021·Frontiers in Bioengineering and Biotechnology

Abstract

Autologous chondrocyte implantation (ACI) is a procedure used to treat articular cartilage injuries and prevent the onset of post-traumatic osteoarthritis. In vitro expansion of chondrocytes, a necessary step in ACI, results in the generation of senescent cells that adversely affect the quality and quantity of newly formed cartilage. Recently, a senolytic peptide, fork head box O transcription factor 4-D-Retro-Inverso (FOXO4-DRI), was reported to selectively kill the senescent fibroblasts. In this study, we hypothesized that FOXO4-DRI treatment could remove the senescent cells in the expanded chondrocytes, thus enhancing their potential in generating high-quality cartilage. To simulate the in vitro expansion for ACI, chondrocytes isolated from healthy donors were expanded to population doubling level (PDL) 9, representing chondrocytes ready for implantation. Cells at PDL3 were also used to serve as the minimally expanded control. Results showed that the treatment of FOXO4-DRI removed more than half of the cells in PDL9 but did not significantly affect the cell number of PDL3 chondrocytes. Compared to the untreated control, the senescence level in FOXO4-DRI treated PDL9 chondrocytes was significantly reduced. Based on the result from standard pellet culture, FOXO4-DRI pre-treatment did not enhance the chondrogenic potential of PDL9 chondrocytes. However, the cartilage tissue generated from FOXO4-DRI pretreated PDL9 cells displayed lower expression of senescence-relevant secretory factors than that from the untreated control group. Taken together, FOXO4-DRI is able to remove the senescent cells in PDL9 chondrocytes, but its utility in promoting cartilage formation from the in vitro expanded chondrocytes needs further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2021.677576

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. Ackermann, 2019, Increased chondrocytic gene expression is associated with improved repair tissue quality and graft survival in patients after autologous chondrocyte implantation., Am. J. Sports Med., 47, 2919, 10.1177/0363546519868213 · DOI
  2. Andriolo, 2017, Failure of autologous chondrocyte implantation., Sports Med. Arthroscopy Rev., 25, 10, 10.1097/jsa.0000000000000137 · DOI
  3. Ashraf, 2016, Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration., Osteoarthritis Cartil., 24, 196, 10.1016/j.joca.2015.07.008 · DOI
  4. Cha, 2013, The modulation of the oxidative stress response in chondrocytes by Wip1 and its effect on senescence and dedifferentiation during in vitro expansion., Biomaterials, 34, 2380, 10.1016/j.biomaterials.2012.12.009 · DOI
  5. Charlier, 2019, Chondrocyte dedifferentiation and osteoarthritis (OA)., Biochem. Pharm., 165, 49, 10.1016/j.bcp.2019.02.036 · DOI
  6. Davies, 2019, Regenerative medicine: a review of the evolution of autologous chondrocyte implantation (ACI) therapy., Bioengineering, 6, 22, 10.3390/bioengineering6010022 · DOI
  7. Duan, 2017, DNA methylation profiling in chondrocyte dedifferentiation in vitro., J. Cell. Physiol., 232, 1708, 10.1002/jcp.25486 · DOI
  8. Huang, 2016, Cell-based tissue engineering strategies used in the clinical repair of articular cartilage., Biomaterials, 98, 1, 10.1016/j.biomaterials.2016.04.018 · DOI
  9. Jeon, 2018, Senescent cells and osteoarthritis: a painful connection., J. Clin. Invest., 128, 1229, 10.1172/jci95147 · DOI
  10. Jonitz, 2012, TGF-β1 and IGF-1 influence the re-differentiation capacity of human chondrocytes in 3D pellet cultures in relation to different oxygen concentrations., Int. J. Mole. Med., 30, 666, 10.3892/ijmm.2012.1042 · DOI
  11. Jungmann, 2019, Cartilage repair surgery prevents progression of knee degeneration., Knee Surg. Sports Traumatol. Arthros., 27, 3001, 10.1007/s00167-018-5321-8 · DOI
  12. Kreuz, 2019, Long-term clinical and MRI results of matrix-assisted autologous chondrocyte implantation for articular cartilage defects of the knee., Cartilage, 10, 305, 10.1177/1947603518756463 · DOI
  13. Lai, 2013, Stem cells catalyze cartilage formation by neonatal articular chondrocytes in 3D biomimetic hydrogels., Sci. Reports, 3
  14. Li, 2012, Cell senescence: a challenge in cartilage engineering and regeneration., Tissue Eng. B Rev., 18, 270, 10.1089/ten.teb.2011.0583 · DOI
  15. Ma, 2013, Gene expression profiling of dedifferentiated human articular chondrocytes in monolayer culture., Osteoarthr. Cartil., 21, 599, 10.1016/j.joca.2013.01.014 · DOI
  16. Moussavi-Harami, 2004, Oxygen effects on senescence in chondrocytes and mesenchymal stem cells: consequences for tissue engineering., Iowa Orthopaedic J., 24, 15
  17. Niemeyer, 2012, Influence of cell quality on clinical outcome after autologous chondrocyte implantation., Am. J. Sports Med., 40, 556, 10.1177/0363546511428879 · DOI
  18. Parsch, 2002, Replicative aging of human articular chondrocytes during ex vivo expansion., Arthritis Rheum., 46, 2911, 10.1002/art.10626 · DOI
  19. Pei, 2012, Extracellular matrix deposited by synovium-derived stem cells delays replicative senescent chondrocyte dedifferentiation and enhances redifferentiation., J. Cell. Physiol., 227, 2163, 10.1002/jcp.22950 · DOI
  20. Pham, 2020, Adipose-derived stem cells can replace fibroblasts as cell control for anti-tumor screening assay., OncoTargets Ther., 13, 6417, 10.2147/ott.s259114 · DOI
  21. Pietschmann, 2009, Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee., Knee Surg. Sports Traumatol. Arthroscopy, 17, 1305, 10.1007/s00167-009-0828-7 · DOI
  22. Sassi, 2014, Wnt signaling is involved in human articular chondrocyte de-differentiation in vitro., Biotechnic Histochem., 89, 29, 10.3109/10520295.2013.811285 · DOI
  23. Schulze-Tanzil, 2002, Redifferentiation of dedifferentiated human chondrocytes in high-density cultures., Cell Tissue Res., 308, 371, 10.1007/s00441-002-0562-7 · DOI
  24. Varela-Eirín, 2020, Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis., Aging, 12, 15882, 10.18632/aging.103801 · DOI
  25. Xu, 2017, Transplanted senescent cells induce an osteoarthritis-like condition in mice., J. Gerontol. A Biol. Sci. Med. Sci., 72, 780
  26. Yang, 2020, Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis., Aging, 12, 12750, 10.18632/aging.103177 · DOI
  27. Yang, 2018, Mesenchymal stem cell-derived extracellular matrix enhances chondrogenic phenotype of and cartilage formation by encapsulated chondrocytes in vitro and in vivo., Acta Biomater., 69, 71, 10.1016/j.actbio.2017.12.043 · DOI
  28. Zhang, 2020, FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice., Aging, 12, 1272, 10.18632/aging.102682 · DOI

Cited by

Sorted by citations

Metadata

Authors
Huang, Y., He, Y., Makarcyzk, M. J., & Lin, H.
Venue
Frontiers in Bioengineering and Biotechnology
Published
2021-04-29
Volume
9
ISSN
2296-4185
Cited by
53
References
4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review